LexDanaLexDanabeta
Inventor

Moses Moustakim

Inventor
US

Overview

4→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes27%
PatentTitleYear
12,559,492BRAF degraders202612,157,735Compounds for targeted degradation of BRD9202412,049,464Compounds for targeted degradation of BRD9202411,691,972Compounds for targeted degradation of BRD92023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to C4 THERAPEUTICS INC (4)· patent assignee history
2023–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
C4 THERAPEUTICS INC42023–2026
Locations
LocationPatentsSpan
US42023–2026